Security
ChronoScale Holdings Corp · CHRN
CHRNNASDAQCommon stockCurrentCIK 1549084Updated Oct 14, 2026
Name history
ChronoScale Corp · through Jul 1, 2026EKSO BIONICS HOLDINGS, INC. · through May 5, 2026PN Med Group Inc · through Dec 31, 2013
CHRN price & chart
Loading TradingView…
NASDAQ:CHRN on TradingView ↗In the news
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth ↗
Seeking Alpha
At a glance: stocks gapping up premarket ↗
Biggest stock movers Friday: NKE, SYNA, and more ↗
ChronoScale expands and adds new AI deals towards $1B revenue run rate ↗
SEC disclosures
ChronoScale Holdings Corp files 8-K: Material Event ↗
Recent filings
EFFECT filing
S-8 POS filing
S-8 POS filing
S-8 POS filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 325,874,000Source | 20,111,000Source | 26,652,000Source | 28,918,000Source |
| Property, Plant and Equipment, NetUSD | 32,081,000Source | 1,288,000Source | 1,577,000Source | 2,018,000Source |
| GoodwillUSD | 54,513,000Source | 431,000Source | 431,000Source | 431,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 3,500,000Source | 4,580,000Source | 4,892,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 9,664,000Source | 1,169,000Source | 6,493,000Source | 8,638,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 12,542,000Source | 7,308,000Source | 7,238,000Source | 5,645,000Source |
| Inventory, NetUSD | — | 4,822,000Source | 4,571,000Source | 5,050,000Source |
| Assets, CurrentUSD | 44,247,000Source | 14,049,000Source | 18,843,000Source | 20,208,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,200,000Source | 750,000Source | 541,000Source | 875,000Source |
| Operating Lease, Right-of-Use AssetUSD | 72,004,000Source | 532,000Source | 788,000Source | 977,000Source |
| Other Assets, NoncurrentUSD | 520,000Source | 311,000Source | 433,000Source | 392,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 143,837,000Source | 11,084,000Source | 13,945,000Source | 16,312,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 145,000Source | 37,000Source | 22,000Source | 15,000Source |
| Additional Paid in CapitalUSD | 379,342,000Source | 272,078,000Source | 262,203,000Source | 251,580,000Source |
| Retained Earnings (Accumulated Deficit)USD | -199,462,000Source | -262,396,000Source | -250,475,000Source | -239,145,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | -692,000Source | 957,000Source | 156,000Source |
| Stockholders' Equity Attributable to ParentUSD | 180,025,000Source | 9,027,000Source | 12,707,000Source | 12,606,000Source |
| Liabilities and EquityUSD | 325,874,000Source | 20,111,000Source | 26,652,000Source | 28,918,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 86,891,000Source | 8,636,000Source | 7,537,000Source | 8,117,000Source |
| Operating Lease, Liability, CurrentUSD | 18,130,000Source | 441,000Source | 427,000Source | 363,000Source |
| Accounts Payable, CurrentUSD | 9,052,000Source | 1,431,000Source | 1,552,000Source | 1,847,000Source |
| Operating Lease, Liability, NoncurrentUSD | 40,289,000Source | 147,000Source | 452,000Source | 723,000Source |
| Other Liabilities, NoncurrentUSD | — | 89,000Source | 181,000Source | 105,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 3,740,000Source | 1,779,000Source | 2,352,000Source | 2,664,000Source |
| Long-term Debt, Current MaturitiesUSD | 3,370,000Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 474,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 60,340,000Source | 1,573,000Source | 1,608,000Source | 1,698,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,297,000Source | 1,474,000Source | 1,373,000Source | 1,858,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 8,544,000Source | -446,000Source | 1,967,000Source | 1,208,000Source |
| Increase (Decrease) in InventoriesUSD | — | 275,000Source | -257,000Source | -232,000Source |
| Increase (Decrease) in Accounts PayableUSD | 4,565,000Source | -137,000Source | -288,000Source | -1,307,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 39,067,000Source | -11,801,000Source | -9,846,000Source | -12,054,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -25,169,000Source | -188,000Source | -37,000Source | -157,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 188,000Source | 37,000Source | 157,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -6,632,000Source | 6,629,000Source | 7,769,000Source | 348,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 7,266,000Source | -5,324,000Source | -2,145,000Source | -11,887,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 1,169,000Source | 6,493,000Source | 8,638,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 9,532,000Source | 118,000Source | 182,000Source | 191,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 36,000Source | -31,000Source | -24,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,297,000Source | 1,474,000Source | 1,373,000Source | 1,858,000Source |
| DepreciationUSD | 5,725,000Source | 563,000Source | 658,000Source | 726,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | 1,000Source | 474,000Source | -133,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | 1,965,000Source | -965,000Source | 412,000Source |
| Gain (Loss) on Disposition of AssetsUSD | -598,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | 9,986,000Source | 8,789,000Source | 10,694,000Source |
| GoodwillUSD | 54,513,000Source | 431,000Source | 431,000Source | 431,000Source |
| Goodwill, Impairment LossUSD | — | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | 750,000Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | 750,000Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -49,300,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -1,020,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| InterestExpenseNonoperatingUSD | — | 309,000Source | 269,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | -50,320,000Source | -11,695,000Source | -11,330,000Source | -15,198,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -50,433,000Source | -11,921,000Source | — | -15,198,000Source |
| Nonoperating Income (Expense)USD | — | 1,631,000Source | -870,000Source | -86,000Source |
| Operating ExpensesUSD | — | 20,171,000Source | 19,971,000Source | 24,191,000Source |
| Operating Lease, ExpenseUSD | — | 611,000Source | 588,000Source | 548,000Source |
| Other Nonoperating Income (Expense)USD | -8,000Source | -26,000Source | -1,000Source | -63,000Source |
| Proceeds from Contributions from ParentUSD | 75,435,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | 15,750,000Source | 4,098,000Source | 9,019,000Source | 661,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | 12,799,000Source | 17,925,000Source | 18,279,000Source |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 71,604,000Source | — | — | — |
| Cost of RevenueUSD | — | 5,954,000Source | 8,414,000Source | 9,200,000Source |
| Selling, General and Administrative ExpenseUSD | 19,812,000Source | — | — | — |
| Operating Income (Loss)USD | -37,497,000Source | -13,326,000Source | -10,460,000Source | -15,112,000Source |
| Other Nonoperating Income (Expense)USD | -8,000Source | -26,000Source | -1,000Source | -63,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -49,300,000Source | -11,695,000Source | -11,330,000Source | -15,198,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -50,320,000Source | -11,695,000Source | -11,330,000Source | -15,198,000Source |
| Earnings Per Share, BasicUSD per share | -0.36Source | -4.91Source | -0.56Source | -1.1Source |
| Earnings Per Share, DilutedUSD per share | -0.36Source | -4.91Source | — | -1.1Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 138,698,000Source | 2,426,000Source | 20,161,000Source | 13,867,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 138,698,000Source | — | 20,161,000Source | 13,867,000Source |
| Interest Expense (non-operating)USD | — | 309,000Source | 269,000Source | — |
| Additional Financial Items | ||||
| Business Combination, Acquisition Related CostsUSD | 5,363,000Source | — | — | — |
| Costs and ExpensesUSD | 109,101,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | 9,986,000Source | 8,789,000Source | 10,694,000Source |
| Goodwill, Impairment LossUSD | — | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | 6,845,000Source | 9,511,000Source | 9,079,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -49,300,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -49,300,000Source | -11,400,000Source | -11,576,000Source | -13,521,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -0.35Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | -0.35Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -1,020,000Source | — | — | — |
| Interest ExpenseUSD | — | — | — | 302,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -9,583,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -50,433,000Source | -11,921,000Source | — | -15,198,000Source |
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, BasicUSD | -49,300,000Source | — | — | — |
| Nonoperating Income (Expense)USD | — | 1,631,000Source | -870,000Source | -86,000Source |
| Operating ExpensesUSD | — | 20,171,000Source | 19,971,000Source | 24,191,000Source |
| Operating Lease, ExpenseUSD | — | 611,000Source | 588,000Source | 548,000Source |
| Research and Development ExpenseUSD | — | 3,031,000Source | 3,874,000Source | 5,025,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | 12,799,000Source | 17,925,000Source | 18,279,000Source |
| Selling and Marketing ExpenseUSD | — | 7,154,000Source | 7,308,000Source | 8,472,000Source |
Offerings
Registration 333-299333
Registration 333-297176
Filing attachments
ex107.htm · S-3 · 2026-10-06
Calculation of Filing Fee Tables S-3 ChronoScale Holdings Corp ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price P…
Read attachment ↗ex4-1.htm · S-3 · 2026-10-06
Exhibit 4.1 CHRONOSCALE HOLDINGS CORPORATION, as Issuer and ●, as Trustee INDENTURE Dated as of ● Senior Debt Securities CROSS REFERENCE SHEET 1 Between Provisions of the Trust Indenture Act of 1939 and the Indenture to be dated as of _________, 20____ between CHRONOSCALE HOLDINGS CORPORATION and ___________________, as Trustee: Section Section of the Act of Indenture 310(a)(1) 5.08 and (2) 310(a)(3) Inapplicable and (4) 310(b)…
Read attachment ↗ex4-2.htm · S-3 · 2026-10-06
Exhibit 4.2 CHRONOSCALE HOLDINGS CORPORATION, as Issuer and ●, as Trustee INDENTURE Dated as of ● Subordinated Debt Securities CROSS REFERENCE SHEET 1 Between Provisions of the Trust Indenture Act of 1939 and the Indenture to be dated as of _________, 20___ between CHRONOSCALE HOLDINGS CORPORATION and ___________________, as Trustee: Section Section of the Act of Indenture 310(a)(1) 5.08 and (2) 310(a)(3) Inapplicable and (4) 3…
Read attachment ↗ex4-3.htm · S-3 · 2026-10-06
Exhibit 4.3 CHRONOSCALE HOLDINGS CORPORATION, ISSUER AND ●, TRUSTEE JUNIOR SUBORDINATED INDENTURE DATED AS OF ● PROVIDING FOR ISSUANCE OF JUNIOR SUBORDINATED DEBT SECURITIES IN SERIES CROSS-REFERENCE TABLE (1) TRUST SECTION INDENTURE ACT SECTION OF INDENTURE 310(a) 7.09 310(b) 7.08 311(a) 7.13 311(b) 7.13 312(a) 5.01; 5…
Read attachment ↗ex99-1.htm · 8-K · 2026-10-02
Exhibit 99.1 Next-Gen Hybrid AI ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 billion by calendar Q3 2027 ChronoScale completes previously disclosed sale of Ekso Bionics business unit MENLO P…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-27
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 ChronoScale Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America Menlo Park, CA - August 27, 2026 - ChronoScale Corporation (NASDAQ: CHRN), (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced plans with Microsoft for a 50-megawatt (MW) AI compute deployment in North America. The deployment will feat…
Read attachment ↗